Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Circulation Research

• Publication date

  2000-10-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.RES.87.9.746PMID 11055977
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes

  2002cited by this paper
• Potentiation of Rho-A mediated LPA activity by hyperinsulinemia

  2000cited by this paper
• Potentiation of Rho-A-mediated Lysophosphatidic Acid Activity by Hyperinsulinemia*

  2000cited by this paper
• Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kB

  1999cited by this paper
• Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants.

  1999cited by this paper
• Insulin Promotes Phosphorylation and Activation of Geranylgeranyltransferase II

  1999cited by this paper
• Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB.

  1999cited by this paper
• Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells.

  1999cited by this paper
• Multiple signals converging on NF-kappaB.

  1999cited by this paper
• Hyperglycemia and the pathogenesis of atherosclerosis: lessons from murine models.

  1999cited by this paper
• Cooperativity between Oxidants and Tumor Necrosis Factor in the Activation of Nuclear Factor (NF)- κ B

  1999cited by this paper
• Multiple signals converging on NF-κB

  1999cited by this paper
• Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animals

  1999cited by this paper
• Activation of Serum Response Factor by RhoA Is Mediated by the Nuclear Factor-κB and C/EBP Transcription Factors*

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Diabetes is a Vascular Disease

  1998cited by this paper
• Insulin potentiates platelet-derived growth factor action in vascular smooth muscle cells.

  1998cited by this paper
• Multiple Signalling Pathways Lead to the Activation of the Nuclear Factor κB by the Rho Family of GTPases*

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Insulin and risk of cardiovascular disease: a meta-analysis.

  1998cited by this paper
• Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion.

  1998cited by this paper
• Effect of Insulin on Farnesyltransferase

  1998cited by this paper
• Rho GTPases and the actin cytoskeleton.

  1998cited by this paper
• The Diabetes Control and Complications Trial

  1998cited by this paper
• Glycation, oxidation, and lipoxidation in the development of the complications of diabetes: a carbonyl stress hypothesis.

  1997cited by this paper
• NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules.

  1997cited by this paper
• Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress*

  1997cited by this paper
• Differences Between Nisoldipine and Lisinopril on Glomerular Filtration Rates and Albuminuria in Hypertensive IDDM Patients With Diabetic Nephropathy During the First Year of Treatment

  1997cited by this paper
• The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis*

  1997cited by this paper
• NF-?B as a Frequent Target for Immunosuppressive and

  1997cited by this paper
• Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-mitogen-activated protein kinase pathway.

  1997cited by this paper
• Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins.

  1997cited by this paper
• Advanced Glycation End Product-Induced Activation of NF-κB is Suppressed by α-Lipoic Acid in Cultured Endothelial Cells

  1997cited by this paper
• Effect of Insulin on Farnesyltransferase Activity in 3T3-L1 Adipocytes*

  1996cited by this paper
• Insulin and the Vasculature—Old Actors, New Roles

  1996cited by this paper
• rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation

  1996cited by this paper
• The role of oxidative stress in diabetic complications

  1996cited by this paper
• NF-kappa B: ten years after.

  1996cited by this paper
• Protein prenylation: molecular mechanisms and functional consequences.

  1996cited by this paper
• NF-κB: Ten Years After

  1996cited by this paper
• Hyperinsulinemia as an independent risk factor for ischemic heart disease.

  1996cited by this paper
• Hyperinsulinemia and Atherosclerosis

  1996cited by this paper
• Vascular actions of insulin in health and disease.

  1995cited by this paper
• Hyperinsulinemia and atherosclerosis.

  1995cited by this paper
• Vascular smooth muscle cells express a constitutive NF-kappa B-like activity.

  1994cited by this paper
• Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis.

  1994cited by this paper
• Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• George Lyman Duff Memorial Lecture. Atherogenesis in diabetes.

  1992cited by this paper
• Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1).

  1992cited by this paper
• Expression of intercellular adhesion molecule-1 in atherosclerotic plaques.

  1992cited by this paper
• Stimulation of endothelin-1 gene expression by insulin in endothelial cells.

  1991cited by this paper
• Sequence dependence of protein isoprenylation.

  1991cited by this paper
• Protein farnesyltransferase and geranylgeranyltransferase share a common alpha subunit.

  1991cited by this paper
• Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

  1991cited by this paper
• Protein farnesyltransferase and geranylgeranyltransferase share a common α subunit

  1991cited by this paper
• Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells.

  1991cited by this paper
• ADP-ribosylation of the bovine brain rho protein by botulinum toxin type C1.

  1988cited by this paper
• Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

  1988cited by this paper
• Diabetes and atherosclerosis: an epidemiologic view.

  1987cited by this paper
• Non‐enzymatic glycosylation of human serum lipoproteins Elevated ϵ‐lysine glycosylated low density lipoprotein in diabetic patients

  1981cited by this paper
• Relationship of Glucose Tolerance and Plasma Insulin to the Incidence of Coronary Heart Disease: Results from Two Population Studies in Finland

  1979cited by this paper
• Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland.

  1979cited by this paper
• Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

  1979cited by this paper
• Insulin and atheroma.

  1969cited by this paper

• Retinol-binding protein 4 in cardiovascular diseases: mechanisms and therapeutic perspectives

  2026cites this paper
• Estimated glucose disposal rate and non-HDL-c/HDL-c ratio with the progression of carotid atherosclerosis: a long-term cohort study

  2025cites this paper
• Sex-specific association between triglyceride-glucose index and all-cause mortality in patients with osteoporotic fractures: a retrospective cohort study

  2025cites this paper
• Association of Glutathione Peroxidase 3 (GPx3) and miR-196a with Carbohydrate Metabolism Disorders in the Elderly

  2024cites this paper
• The Renin–Angiotensin System and Cardiovascular–Kidney–Metabolic Syndrome: Focus on Early-Life Programming

  2024cites this paper
• A high triglyceride-glucose index associated with adverse cardiovascular events in patients with type 2 diabetes mellitus and chronic total occlusion after percutaneous coronary intervention

  2023cites this paper
• Free Radicals and Obesity-Related Chronic Inflammation Contrasted by Antioxidants: A New Perspective in Coronary Artery Disease

  2023cites this paper
• DPP4 Activity, Hyperinsulinemia and Atherosclerosis.

  2021cites this paper
• High Triglyceride-Glucose Index (TyG) is Associated With Adverse Cardiovascular Events in Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Total Occlusion (CTO) After Percutaneous Coronary Intervention (PCI)

  2021cites this paper
• Diabetes and the Cardiovascular System

  2020cites this paper
• Insulin Resistance and Atherosclerosis: Implications for Insulin Sensitizing Agents.

  2019cites this paper
• Predictors of death in patients with myocardial ischemia and infarction

  2018cites this paper
• Anti-inflammatory Action of Metformin with Respect to CX3CL1/CX3CR1 Signaling in Human Placental Circulation in Normal-Glucose Versus High-Glucose Environments

  2018cites this paper
• High Glucose Level Disturbs the Resveratrol-Evoked Curtailment of CX3CL1/CX3CR1 Signaling in Human Placental Circulation

  2017cites this paper
• Latent Inflammation and Insulin Resistance in Adipose Tissue

  2017cites this paper
• miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes

  2017cites this paper
• Erk 5 and P 38 Kinase are Positive Regulators of Insulin and Tnf α-Stimulated Vcam-1 Expression in Rat Aorta Endothelial Cells

  2017cites this paper
• Influencia de los anticuerpos anti-LDL oxidada y del control glucémico sobre diferentes rutas metabólicas implicadas en la aterogénesis en pacientes con enfermedad arterial periférica y diabetes tipo 2.

  2017cites this paper
• upregulation in hyperglycemia-activated endothelial cells

  2016cites this paper
• Blood glucose control using a computer-guided glucose management system in allogeneic hematopoietic cell transplant recipients

  2016cites this paper
• Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns

  2015cites this paper
• Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies.

  2015cites this paper
• Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes.

  2015cites this paper
• Regulation of pancreatic beta-cell function by the renin-angiotensin system in type 2 diabetes

  2015cites this paper
• Cardiovascular Manifestations of Hyperglycemia: A Review Article

  2014cites this paper
• Diabetes mellitus tipo 2: qual o papel da insulina na expressão de NF-kappaB, PPARγ e CD36? Type 2 diabetes: What is the role of insulin in NF-kappaB, PPARγ and CD36 expression?

  2014cites this paper
• Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

  2014cites this paper
• Functional status of vascular endothelium in diabetes mellitus.

  2014cites this paper
• Dietary Hyperlipidemia and Retinal Microaneurysms

  2014cites this paper
• Effect of dietary nitrate on blood pressure, endothelial function, and insulin sensitivity in type 2 diabetes.

  2013cites this paper
• Diabetes Protects from Prostate Cancer by Downregulating Androgen Receptor: New Insights from LNCaP Cells and PAC120 Mouse Model

  2013cites this paper
• Advanced glycation end products. A new biomarker of diabetes and late complications of disease

  2013cites this paper
• Epigenetic Regulation of Vascular Smooth Muscle Cell Function in Atherosclerosis

  2013cites this paper
• Новые возможности профилактики сахарного диабета 2-го типа

  2013cites this paper
• Nuclear-factor k B p 65 is a mediator of insulin and tumour necrosis factor-alpha stimulated vascular cell adhesion molecule-1 expression in vascular endothelial cells

  2013cites this paper
• Rosiglitazone attenuates NF-κB-mediated Nox4 upregulation in hyperglycemia-activated endothelial cells.

  2012cites this paper
• Glycemic Management in the Inpatient Setting

  2012cites this paper
• [NF-kB activation as a molecular basis of pathological process by metabolic syndrome].

  2012cites this paper
• Atherogenesis and Diabetes, Focus on Insulin Resistance and Hyperinsulinemia

  2012cites this paper
• The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.

  2012cites this paper
• Aterogénesis y diabetes, resistencia a la insulina e hiperinsulinemia

  2012cites this paper
• Therapy: Part I Diabetes and Vascular Disease : Pathophysiology, Clinical Consequences, and Medical

  2012cites this paper
• Motherhood, apple pie, hemoglobin A(1C), and the DCCT.

  2012cites this paper
• Atherogenesis and diabetes: focus on insulin resistance and hyperinsulinemia.

  2012cites this paper
• [NF-kB activation as a molecular basis of pathological process by metabolic syndrome].

  2012cites this paper
• Cellular and molecular mechanisms of vascular injury in diabetes--part I: pathways of vascular disease in diabetes.

  2011cites this paper
• Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells

  2011cites this paper
• Involvement of membrane type 1‐matrix metalloproteinase (MT1‐MMP) in RAGE activation signaling pathways

  2011cites this paper
• ERK5: A Novel IKKα-Kinase in Rat Hippocampal Neurons

  2011cites this paper
• Effects of insulin on the vasculature.

  2011cites this paper
• Signaling in Diabetes and Metabolic Syndrome

  2011cites this paper
• Management of Inpatient Hyperglycemia

  2011cites this paper
• ExEcUTIvE DIREcTOR OF OPERaTIONS

  2010cites this paper
• Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009

  2010cites this paper
• Multiple cross talk between angiotensin II, bradykinin, and insulin signaling in the cortical thick ascending limb of rat kidney.

  2010cites this paper
• Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms

  2010cites this paper
• Bloqueio do sistema renina-angiotensina atenua lesões em órgãos-alvo em modelo de diabetes mellitus tipo 2 e hipercolesterolemia induzidos por dieta

  2009cites this paper
• Insulin-Like Growth Factor-1 Receptor Expression Masks the Antiinflammatory and Glucose Uptake Capacity of Insulin in Vascular Smooth Muscle Cells

  2009cites this paper
• Safe Insulin Use in the Hospital Setting

  2009cites this paper
• A role for insulin on L-arginine transport in fetal endothelial dysfunction in hyperglycaemia.

  2009cites this paper
• Surgical complications of hyperglycaemia.

  2009cites this paper
• The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning

  2008cites this paper
• From a dull enzyme to something else: facts and perspectives regarding aldose reductase.

  2008cites this paper
• Insulin potentiates cytokine-induced VCAM-1 expression in human endothelial cells.

  2008cites this paper
• [Glycemic control in the coronary care unit: prognostic value and new therapeutic strategies].

  2008cites this paper
• Insulin Resistance and Cardiovascular Disease

  2008cites this paper
• Il controllo glicemico in unità coronarica: valore prognostico e nuove strategie terapeutiche

  2008cites this paper
• Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats.

  2008cites this paper
• The Prominent Role of P38 Mitogen-Activated Protein Kinase in Insulin-Mediated Enhancement of VCAM-1 Expression in Endothelial Cells

  2007cites this paper
• Atherosclerosis in diabetes and insulin resistance

  2007cites this paper
• Achieving durable glucose control in the intensive care unit without hypoglycaemia : a new practical IV insulin protocol

  2007cites this paper
• Synergistic proliferation induced by insulin and glycated serum albumin in rat vascular smooth muscle cells.

  2007cites this paper
• [Insulin and angiotensin II signaling pathways cross-talk: implications with the association between diabetes mellitus, arterial hypertension and cardiovascular disease].

  2007cites this paper
• Angiotensin II Type 1 Receptor Blockade Improves Hyperglycemia-Induced Endothelial Dysfunction and Reduces Proinflammatory Cytokine Release From Leukocytes

  2007cites this paper
• Effects of Insulin Dependence on Inflammatory Process, Thrombotic Mechanisms and Endothelial Function, in Patients with Type 2 Diabetes Mellitus and Coronary Atherosclerosis

  2007cites this paper
• Diabetic Retinopathy: Unraveling the Paradoxical Effects of Intensive Insulin Treatment

  2007cites this paper
• Molecular Activity of Insulin and Selective Insulin Resistance

  2007cites this paper
• Cross-talk das vias de sinalização de insulina e angiotensina II: implicações com a associação entre diabetes mellitus e hipertensão arterial e doença cardiovascular

  2007cites this paper
• Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: bellwether for vascular disease?

  2007cites this paper
• Exchange on the Interleukin-6 Promoter in VSMCs B / RelA Subunit κ Induced Phospho-Ser 536 Nuclear Factor − RhoA Mediates Angiotensin II

  2006cites this paper
• Early growth response gene-1 expression in vascular smooth muscle cells effects of insulin and oxidant stress.

  2006cites this paper
• Inpatient diabetes: review of data from the cardiac care unit.

  2006cites this paper
• The multi‐faceted cross‐talk between the insulin and angiotensin II signaling systems

  2006cites this paper
• Monocyte Chemoattractant Protein-1 – a major contributor to the inflammatory process associated with diabetes

  2006cites this paper
• Síndrome metabólico: ¿cómo diagnosticarlo y cómo tratarlo?

  2006cites this paper
• RhoA Mediates Angiotensin II–Induced Phospho-Ser536 Nuclear Factor &kgr;B/RelA Subunit Exchange on the Interleukin-6 Promoter in VSMCs

  2006cites this paper
• Growth factor receptor-protein bound 2 (GRB2) upregulation in the placenta in preeclampsia implies a possible role for ras signalling.

  2005cites this paper
• Insulin alters nuclear factor-lambdaB and peroxisome proliferator-activated receptor-gamma protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells.

  2005cites this paper
• Potential beneficial mechanisms of insulin (glucose-potassium) in acute myocardial infarction.

  2005cites this paper
• Thrombin-induced Rapid Geranylgeranylation of RhoA as an Essential Process for RhoA Activation in Endothelial Cells*

  2005cites this paper
• Percutaneous coronary revascularization in diabetics: from balloon angioplasty to drug-eluting stents

  2005cites this paper
• Con: tight perioperative glycemic control: poorly supported and risky.

  2005cites this paper
• [Endothelial dysfunction in patients with diabetes: identification, pathogenesis and treatment].

  2005cites this paper
• La cintura hipertrigliceridémica

  2005cites this paper
• Metabolic interventions in acute myocardial infarction

  2005cites this paper
• The Role of Insulin Therapy in Critically I11 Patients

  2005cites this paper
• Insulin alters nuclear factor-κB and peroxisome proliferator-activated receptor-γ protein expression induced by glycated bovine serum albumin in vascular smooth-muscle cells

  2005cites this paper
• How does blood glucose control with insulin save lives in intensive care

  2004cites this paper
• Transcription Factors

  2004cites this paper
• Hypertension in diabetes: The role of the vasculature

  2004cites this paper